RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

被引：0
|
作者：
Hatzivassiliou, Georgia
Song, Kyung
Yen, Lvana
Brandhuber, Barbara J.
Anderson, Daniel J.
Alvarado, Ryan
Ludlam, Mary Jc
Stokoe, David
Gloor, Susan L.
Vigers, Guy
Morales, Tony
Aliagas, Ignacio
Liu, Bonnie
Sideris, Steve
Hoeflich, Klaus
Jaiswal, Bijay S.
Seshagiri, Sonnasekar
Koeppen, Hartmut
Belvin, Marcia
Friedman, Lori S.
Malek, Shiva
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-5753
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5753
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
    Santarpia, Libero
    Lippman, Scott M.
    El-Naggar, Adel K.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 103 - 119
  • [32] Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
    Wu, Pui-Kei
    Becker, Andrew
    Park, Jong-In
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 12
  • [33] Efficacy of a novel small molecule MER receptor tyrosine kinase inhibitor in B-RAF wild-type and B-RAF mutant melanoma cell lines
    Teodorovic, Lenka S.
    Carrico, Jacqueline
    DeRyckere, Deborah
    Zhang, Weihe
    Wang, Xiaodong
    Frye, Stephen
    Eckhardt, S. Gail
    Earp, H. Shelton
    Graham, Douglas K.
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Oncogenic properties via MAPK signaling of the SOX5-RAF1 fusion gene identified in a wild-type NRAS/BRAF giant congenital nevus
    Vinyals, Antonia
    Ferreres, Josep R.
    Calbet-Llopart, Neus
    Ramos, Raquel
    Tell-Marti, Gemma
    Carrera, Cristina
    Marcoval, Joaquim
    Puig, Susana
    Malvehy, Josep
    Puig-Butille, Joan Anton
    Fabra, Angels
    PIGMENT CELL & MELANOMA RESEARCH, 2022, 35 (04) : 450 - 460
  • [35] AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
    Emilia Caputo
    Roberta Miceli
    Maria Letizia Motti
    Rosarita Taté
    Federica Fratangelo
    Gerardo Botti
    Nicola Mozzillo
    Maria Vincenza Carriero
    Ernesta Cavalcanti
    Giuseppe Palmieri
    Gennaro Ciliberto
    Giuseppe Pirozzi
    Paolo Antonio Ascierto
    Journal of Translational Medicine, 12
  • [36] AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
    Caputo, Emilia
    Miceli, Roberta
    Motti, Maria Letizia
    Tate, Rosarita
    Fratangelo, Federica
    Botti, Gerardo
    Mozzillo, Nicola
    Carriero, Maria Vincenza
    Cavalcanti, Ernesta
    Palmieri, Giuseppe
    Ciliberto, Gennaro
    Pirozzi, Giuseppe
    Ascierto, Paolo Antonio
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [37] AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
    Emilia Caputo
    Roberta Miceli
    Maria L. Motti
    Rosarita Taté
    Federica Fratangelo
    Gerardo Botti
    Nicola Mozzillo
    Maria V Carriero
    Ernesta Cavalcanti
    Giuseppe Palmieri
    Gennaro Ciliberto
    Giuseppe Pirozzi
    Paolo A Ascierto
    Journal of Translational Medicine, 13 (Suppl 1)
  • [38] In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors
    Basile, Kevin J.
    Abel, Ethan V.
    Dadpey, Neda
    Hartsough, Edward J.
    Fortina, Paolo
    Aplin, Andrew E.
    CANCER RESEARCH, 2013, 73 (23) : 7101 - 7110
  • [39] Molecular Analysis of the Ras-Raf-MAPK Pathway in Langerhans Cell Histiocytosis
    Solomon, David
    Joseph, Nancy
    Grenert, James
    Horvai, Andrew
    MODERN PATHOLOGY, 2015, 28 : 27A - 27A
  • [40] RAF1 amplification: an exemplar of MAPK pathway activation in urothelial carcinoma
    Clark-Garvey, Sean
    Kim, William Y.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (22):
12345